anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Sequoia Pitch

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 43,093
Current window 25,531-25,560
Pages 1,437
Rows per page 30
Arc: Sequoia Pitchclear collectionreset all
18 30 60

Arc

25,531-25,560 of 43,093

filter-aware
16
DCR stands for Disease Control Rate. The table compares historical benchmarks (Standard of Care) against the company's clinical trial results (THIO-101).MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
17
Data presented in a table format with footnotes explaining the methodology for DCR calculation.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
18
DCR = Disease Control Rate. Data shows high efficacy across all tested dose levels.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
19
Clinical trial data visualization showing patient-level outcomes over time.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
20
The chart tracks individual patient outcomes over time, including treatment status, response type, and study exit reasons.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
21
The plot highlights long-term benefit post-therapy and low mortality rates in the cohort.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
33
MAIA Biotechnology | Investor Presentation Deck | 39 slidesMAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Team1 hit
04
Main Street Capital | Investor Presentation Deck | 49 slidesMain Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Problem1 hit
05
Main Street Capital | Investor Presentation Deck | 49 slidesMain Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Problem1 hit
06
Main Street Capital | Investor Presentation Deck | 49 slidesMain Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Solution1 hit
07
The slide uses a numbered list structure to define the core pillars of the investment strategy.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Solution1 hit
10
LMM stands for Lower Middle Market.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Market Size1 hit
34
Includes year-over-year percentage changes for each period.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Financials1 hit
35
The chart uses a combination of bar and line graphs to demonstrate long-term financial performance.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
36
The slide emphasizes the benefits of an internal management structure over external management.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Financials1 hit
37
The chart highlights MAIN's efficiency by showing its operating expenses are lower than the peer group averages.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Financials1 hit
38
Includes detailed breakdown of investment income, expenses, non-cash compensation, and net asset changes.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Financials1 hit
39
The table tracks the bridge from beginning NAV to ending NAV per share, including income, expenses, dividends, and share issuance impacts.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Financials1 hit
40
Includes footnotes regarding credit facilities and specific notes payable details.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Financials1 hit
41
Includes detailed footnotes explaining debt components and ratio calculation methodologies.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Financials1 hit
05
The slide uses a combination of molecular diagrams and bulleted lists to explain the mechanism and benefits of the LNC technology.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Product1 hit
06
Technical scientific slide detailing the mechanism of action for a drug delivery platform.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Product1 hit
07
The LNC column is highlighted in light yellow to emphasize the company's proprietary technology.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Product1 hit
08
Matinas BioPharma | Investor Presentation Deck | 31 slidesMatinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Product1 hit
09
Uses authority-citation to establish urgency and market relevance.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
Uses a 'Before-After-Bridge' style logic (Characteristics - Limitations = Unlocked Potential).Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
30
Matinas BioPharma | Investor Presentation Deck | 31 slidesMatinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Team1 hit
04
Includes a detailed inset map for Hawaii and a legend defining service routes and office types.Matson | Investor Presentation Deck | 14 slides · Matson
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
05
The slide uses a table-like layout to pair high-level strategic pillars with specific supporting bullet points.Matson | Investor Presentation Deck | 14 slides · Matson
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
06
Matson | Investor Presentation Deck | 14 slidesMatson | Investor Presentation Deck | 14 slides · Matson
Pitch deck Investor relations Beat · Problem1 hit